Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition and method for managing redness of skin associated with dermatological condition

a dermatological condition and skin technology, applied in the field of rosacea treatment, can solve the problems of skin irritation, retinoids are often irritants, drug side effects, etc., and achieve the effects of reducing inflammation or rosacea, reducing skin irritation, and facilitating skin cleansing

Inactive Publication Date: 2007-10-25
WATSON DANA M
View PDF3 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009] U.S. Pat. No. 5,994,330, El Khoury, issued Nov. 30, 1999, describes the treatment of acne and other inflammatory skin conditions using topically administered muscarinic agents. The therapeutic effects of the invention are said to include a decrease in redness, swelling and inflammation.
[0010] U.S. Pat. No. 5,968,532, De Lacharriere, et al., issued Oct. 19, 1999, describes the use of an ethylene diamine derivative in a cosmetic or dermatological composition containing a material having an irritant side effect. The ethylene diamine derivative is said to minimize skin irritation, erythema and sensations of inflammation or rosacea stemming from the use of the cosmetic / dermatological product.
[0011] U.S. Pat. No., 5,885,595, Corey, et al., issued Mar. 23, 1999, describes a cosmetic composition which includes a retinal fatty acid ester. The composition is said to be effective for treating chronoaging conditions of the skin and dermatological disorders including acne, follicular and lesional papules, actinic kertoses, oily skin and rosacea.
[0012] U.S. Pat. No. 6,071,541, Murad, issued Jun. 6, 2000, describes the use of a topical composition which contains a hydroxy acid or tannic acid to exfoliate a portion of the skin, stabilized hydrogen peroxide to facilitate cleansing of the skin, and an antimicrobial agent to inhibit or reduce microorganisms of the skin. The composition is said to be effective in the treatment and management of inflammatory skin conditions, such as acne and acneiform rosacea.
[0013] U.S. Pat. No. 6,057,341, Charpentier, issued May 2, 2000, describes pharmaceutical or cosmetic composition which include novel bi-aromatic dibenzofuran derivatives. The compositions are said to exhibit pharmacological responses of the retinoid agonist type and are further said t be effective in treating keratinization disorders, including acne rosacea.
[0014] U.S. Pat. No. 5,886,233, Steinmeyer, et al., issued Mar. 23, 1999, describes cyclohexanone derivatives used to synthesize vitamin D compounds. The compounds are said to be useful for treating skin, such as in the treatment of acne.

Problems solved by technology

Systemic and topical antibiotics include tetracycline, metronidazole, erythromycin, minocycline, and clindamycin, but the use of these agents is often accompanied by drug side effects, the development of resistance, and changes in the normal microbial flora.
Retinoids are often irritants and are not advised for individuals with sensitive skin.
Retinoids can also be phototoxic and they can induce thin and easily bruisable, fragile skin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0037] Using the Listed Concentrations of the Present Invention:

Deionized Water48.60%SD39C Alcohol35.00%Aloe Vera3.00%Caprylic / Capric Triglyceride5.00%Hepes Linoleate4.00%Evening Primrose Oil2.00%Carbopol 9811.00%Sodium Ascorbyl Phosphate0.50%Sorbitan Oleate0.30%Tetrasodium EDTA0.20%Acrylates / C10-30 Alkyl Acrylate Crosspolymer0.20%Vitamin D3 Cholecalcipherol0.10%Peppermint Oil USP0.10%

[0038] Approximately 10 cases of dermatological conditions related to rosacea were treated with the composition. In approximately 85% of the group, the condition was brought under control within two to three weeks of twice daily applications.

example 2

[0039] Using the Listed Concentrations of the Present Invention:

Deionized Water64.60%SD39C Alcohol10.00%Aloe Vera10.00%Caprylic / Capric Triglyceride5.00%Hepes Linoleate6.00%Evening Primrose Oil2.00%Carbopol 9811.00%Sodium Ascorbyl Phosphate0.50%Sorbitan Oleate0.30%Tetrasodium EDTA0.20%Acrylates / C10-30 Alkyl Acrylate Crosspolymer0.20%Vitamin D3 Cholecalcipherol0.10%Peppermint Oil USP0.10%

[0040] Approximately 15 cases of dermatological conditions related to rosacea were treated with the composition. In approximately 70% of the group, the condition was brought under control within two to three weeks of twice daily applications.

example 3

[0041]

Deionized Water58.60%SD39C Alcohol25.00%Aloe Vera5.00%Caprylic / Capric Triglyceride5.00%Hepes Linoleate2.00%Evening Primrose Oil2.00%Carbopol 9811.00%Sodium Ascorbyl Phosphate0.50%Sorbitan Oleate0.30%Tetrasodium EDTA0.20%Acrylates / C10-30 Alkyl Acrylate Crosspolymer0.20%Vitamin D3 Cholecalcipherol0.10%Peppermint Oil USP0.10%

[0042] Approximately 20 cases of dermatological conditions related to rosacea were treated with the composition. In approximately 90% of the group, the condition was brought under control within two to three weeks of twice daily applications.

[0043] In these examples, the patients chosen ranged in ages from 25 to 55 years old and ranged in skin tones form very light to medium complexions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

The present invention is directed towards a topical composition for managing redness of skin associated with a dermatological condition, comprising water, gelled ethyl alcohol (an anti-bacterial), anti-oxidants, thickening agents, emulsifiers, stabilizers, and a natural esterified anti-inflammatory (Hepes). This combined therapy is more effective than anti-bacterial agents alone and is particularly effective for those who do not respond well to the solutions containing only anti-bacterial agents.

Description

BACKGROUND OF INVENTION [0001] The present invention relates to the treatment of a dermatological condition and, more specifically, to the treatment of rosacea, by a topical application of a composition comprising a combination of gelled ethyl alcohol and Hepes Linoleate. The invention relates to topical compositions for the treatment of a dermatological condition and, more specifically, to the treatment of rosacea. The method for treatment preferably includes two to three applications daily to the affected area of the skin. [0002] Rosacea is a chronic inflammatory skin disorder that can develop in the third to sixth decade of life characterized by four distinct clinical stages predominately affecting the central aspect of the face. The disease appears to be more prevalent in northern climates where cold exposure is experienced more often, and in light-skinned persons on whom flushing is common and sensitivity to sunlight is particularly high. The first clinical evidence of rosacea ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K8/81A61K8/73A61K8/37
CPCA61K8/34A61K8/345A61K8/44A61K8/4973A61K8/67A61Q19/00A61K8/8147A61K8/8152A61K8/92A61K8/97A61Q17/005A61K8/676A61K8/9794
Inventor WATSON, DANA M.
Owner WATSON DANA M